XRCC1 and neoplasm: Previous works have demonstrated that XRCC1 is associated with tumor resistance to chemotherapy and radiotherapy, carcinogenesis, and tumor progression (Sak et al., 2005; Hanssen-Bauer et al., 2012; Xu et al., 2014; Li et al., 2018).